Table 2 Clinical chemistry profiles of the study group

FBS, mmole/L

5.0 ± 0.2

6.1 ± 0.3^ab

5.2 ± 0.2

5.5 ± 0.5^a

TC, mg/dL

173.8 ± 7.4

190.3 ± 15.9^ab

178.4 ± 6.9^a

182.7 ± 12.2^a

LDL-C, mg/dL

107.6 ± 6.8

128.1 ± 15.1^ab

111.0 ± 9.3

184.2 ± 12.6^a

HDL-C, mg/dL

42.2 ± 5.3

33.1 ± 2.6^ab

40.7 ± 3.5

38.1 ± 4.7^a

TAG, mg/dL

120.4 ± 7.5

145.3 ± 13.3^ab

133.4 ± 9.7^a

137.1 ± 11.3^a

Hypercholesterolemia, n(%)

0(0)

3 (8.8)

0(0)

3 (8.8)

Elevated LDL-C, n(%)

0(0)

2 (5.9)

0(0)

2 (5.9)

Hypertriglyceridemia, n(%)

0(0)

1 (2.9)

0(0)

1 (2.9)

Reduced HDL-C, n(%)

3 (11.1)

5 (14.7)

1(2.9)

6 (17.6)